Advanced search
Publication Cover
Hematology Volume 29, 2024 - Issue 1
Submit an article Journal homepage
767
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis

Zhiqiang Xua Department of Hematology, ZhongShan Hospital Xiamen University, Xiamen, People’s Republic of China
,
Jieni Yub Department of Hematology, Shaoxing People’s Hospital, Shaoxing, People’s Republic of China
&
Yamei Chena Department of Hematology, ZhongShan Hospital Xiamen University, Xiamen, People’s Republic of ChinaCorrespondence[email protected]
Article: 2323890 | Received 30 Nov 2023, Accepted 22 Feb 2024, Published online: 03 Mar 2024

References

  • Viale PH. The American cancer society’s facts & figures: 2020 edition. J Adv Pract Oncol. 2020;11:135–136.
  • Hanamura I, Stewart JP, Huang Y, et al. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood. 2006;108:1724–1732. doi:10.1182/blood-2006-03-009910
  • Schmidt TM, Fonseca R, Usmani SZ. Chromosome 1q21 abnormalities in multiple myeloma. Blood Cancer J. 2021;11:83. doi:10.1038/s41408-021-00474-8
  • Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015;33:2863–2869. doi:10.1200/JCO.2015.61.2267
  • Kastritis E, Migkou M, Dalampira D, et al. Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implications. Am J Hematol. 2022;97:1142–1149. doi:10.1002/ajh.26639
  • D’Agostino M, Cairns DA, Lahuerta JJ, et al. Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: a European myeloma network (EMN) report within the HARMONY project. J Clin Oncol. 2022;40:3406–3418. doi:10.1200/JCO.21.02614
  • Shen W, Song Z, Zhong X, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1:e36. doi:10.1002/imt2.36
  • Li H, Pei F, Taylor DL, et al. Quartataweb: integrated chemical-protein-pathway mapping for polypharmacology and chemogenomics. Bioinformatics (Oxford, England). 2020;36:3935–3937.
  • Chng WJ, Dispenzieri A, Chim CS, et al. IMWG consensus on risk stratification in multiple myeloma. Leukemia. 2014;28:269–277. doi:10.1038/leu.2013.247
  • Walker BA, Mavrommatis K, Wardell CP, et al. Double-Hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia. 2019;33:159–170. doi:10.1038/s41375-018-0196-8
  • Bedewy AM, El-Maghraby SM. Do baseline cereblon gene expression and IL-6 receptor expression determine the response to thalidomide-dexamethasone treatment in multiple myeloma patients? Eur J Haematol. 2014;92:13–18. doi:10.1111/ejh.12207
  • Thabard W, Barillé S, Collette M, et al. Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage. Clin Cancer Res. 1999;5:2693–2697.
  • Teoh PJ, Chung TH, Chng PYZ, et al. IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification. Haematologica. 2020;105:1391–1404. doi:10.3324/haematol.2019.221176
  • Stephens OW, Zhang Q, Qu P, et al. An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification. Blood. 2012;119:503–512. doi:10.1182/blood-2011-07-367052
  • Kim SY, Min HJ, Park HK, et al. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:810–820. doi:10.1016/j.bbmt.2011.01.002
  • Emery P, Rondon J, Parrino J, et al. Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology (Oxford, England). 2019;58:849–858. doi:10.1093/rheumatology/key361
  • Rawstron AC, Fenton JA, Ashcroft J, et al. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood. 2000;96:3880–3886. doi:10.1182/blood.V96.12.3880
  • Balada E, Felip L, Ordi-Ros J, et al. DUSP23 is over-expressed and linked to the expression of DNMTs in CD4(+) T cells from systemic lupus erythematosus patients. Clin Exp Immunol. 2017;187:242–250. doi:10.1111/cei.12883
  • Tang JP, Tan CP, Li J, et al. VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers. Mol Cancer. 2010;9:128. doi:10.1186/1476-4598-9-128
  • Germain-Lee EL, Obie C, Valle D. NVL: a new member of the AAA family of ATPases localized to the nucleus. Genomics. 1997;44:22–34. doi:10.1006/geno.1997.4856
  • Zhao SG, Evans JR, Kothari V, et al. The landscape of prognostic outlier genes in high-risk prostate cancer. Clin Cancer Res. 2016;22:1777–1786. doi:10.1158/1078-0432.CCR-15-1250

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.